These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18358721)

  • 21. Synthesis and antitubercular activity of monocyclic nitroimidazoles: insights from econazole.
    Lee SH; Kim S; Yun MH; Lee YS; Cho SN; Oh T; Kim P
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1515-8. PubMed ID: 21277200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases.
    Thompson AM; Blaser A; Palmer BD; Anderson RF; Shinde SS; Launay D; Chatelain E; Maes L; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2583-2589. PubMed ID: 28462832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and anti-tuberculosis activity of N-aryl-C-nitroazoles.
    Walczak K; Gondela A; Suwiński J
    Eur J Med Chem; 2004 Oct; 39(10):849-53. PubMed ID: 15464618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Pyrimidines as Antitubercular Agents.
    Inoyama D; Paget SD; Russo R; Kandasamy S; Kumar P; Singleton E; Occi J; Tuckman M; Zimmerman MD; Ho HP; Perryman AL; Dartois V; Connell N; Freundlich JS
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311070
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release.
    Singh R; Manjunatha U; Boshoff HI; Ha YH; Niyomrattanakit P; Ledwidge R; Dowd CS; Lee IY; Kim P; Zhang L; Kang S; Keller TH; Jiricek J; Barry CE
    Science; 2008 Nov; 322(5906):1392-5. PubMed ID: 19039139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and Anti-Mycobacterium tuberculosis Activity of Imidazo[2,1-b][1,3]oxazine Derivatives against Multidrug-Resistant Strains.
    Fernandes GFS; Manieri KF; Bonjorno AF; Campos DL; Ribeiro CM; Demarqui FM; Ruiz DAG; Nascimento-Junior NM; Denny WA; Thompson AM; Pavan FR; Dos Santos JL
    ChemMedChem; 2023 Jun; 18(12):e202300015. PubMed ID: 37002895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.
    Hurdle JG; Lee RB; Budha NR; Carson EI; Qi J; Scherman MS; Cho SH; McNeil MR; Lenaerts AJ; Franzblau SG; Meibohm B; Lee RE
    J Antimicrob Chemother; 2008 Nov; 62(5):1037-45. PubMed ID: 18693235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediates in the reduction of the antituberculosis drug PA-824, (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, in aqueous solution.
    Anderson RF; Shinde SS; Maroz A; Boyd M; Palmer BD; Denny WA
    Org Biomol Chem; 2008 Jun; 6(11):1973-80. PubMed ID: 18480913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of sugar-derived chiral nitroimidazoles as potential antimycobacterial agents.
    Mugunthan G; Sriram D; Yogeeswari P; Ravindranathan Kartha KP
    Carbohydr Res; 2011 Sep; 346(13):1760-6. PubMed ID: 21714959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluation.
    Shalini ; Viljoen A; Kremer L; Kumar V
    Bioorg Med Chem Lett; 2018 May; 28(8):1309-1312. PubMed ID: 29551480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nitroimidazooxazines (PA-824 and analogs): structure-activity relationship and mechanistic studies.
    Denny WA; Palmer BD
    Future Med Chem; 2010 Aug; 2(8):1295-304. PubMed ID: 21426020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1,3-Oxazine-2-one derived dual-targeted molecules against replicating and non-replicating forms of Mycobacterium tuberculosis.
    Velappan AB; Kesamsetty D; Datta D; Ma R; Hari N; Franzblau SG; Debnath J
    Eur J Med Chem; 2020 Dec; 208():112835. PubMed ID: 32977201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis.
    Ashtekar DR; Costa-Perira R; Nagrajan K; Vishvanathan N; Bhatt AD; Rittel W
    Antimicrob Agents Chemother; 1993 Feb; 37(2):183-6. PubMed ID: 8452346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
    Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
    PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antitubercular activity of new mefloquine-oxazolidine derivatives.
    Gonçalves RS; Kaiser CR; Lourenço MC; de Souza MV; Wardell JL; Wardell SM; da Silva AD
    Eur J Med Chem; 2010 Dec; 45(12):6095-100. PubMed ID: 20932608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates.
    Chandramohan Y; Padmanaban V; Bethunaickan R; Tripathy S; Swaminathan S; Ranganathan UD
    J Glob Antimicrob Resist; 2019 Dec; 19():348-353. PubMed ID: 31226332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bactericidal activity of OPC-67683 against drug-tolerant Mycobacterium tuberculosis.
    Saliu OY; Crismale C; Schwander SK; Wallis RS
    J Antimicrob Chemother; 2007 Nov; 60(5):994-8. PubMed ID: 17761500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A concise and convergent synthesis of PA-824.
    Marsini MA; Reider PJ; Sorensen EJ
    J Org Chem; 2010 Nov; 75(21):7479-82. PubMed ID: 20929201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial activity of dihydro-1,3-oxazine derivatives condensed with aromatic rings in positions 5,6.
    Chylińska JB; Janowiec M; Urbański T
    Br J Pharmacol; 1971 Nov; 43(3):649-57. PubMed ID: 5003353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.